Participant Reference to Possible Adverse Effects Associated With PPI Use
| Reference, No. (%) | Primary Care (n = 5) | Cardiology (n = 4) | Gastroenterology (n = 3) | Vascular Surgery (n = 3) |
|---|---|---|---|---|
| Any mention of possible adverse effects | 5 (100) | 2 (50) | 3 (100) | 1 (33.3) |
| Clostridioides difficile or other enteric infection | 4 (80) | 1 (25) | 1 (33.3) | 1 (33.3) |
| Dementia | 4 (80) | 0 (0) | 3 (100) | 0 (0) |
| Pneumonia | 3 (60) | 2 (50) | 1 (33.3) | 1 (33.3) |
| Chronic kidney disease | 3 (60) | 1 (25) | 2 (66.7) | 0 (0) |
| Bone disease | 3 (60) | 0 (0) | 2 (66.7) | 1 (33.3) |
PPI = proton pump inhibitor.